EUVIMEDEUVIMED entdecken
Crossref

An integrated long-acting implant of clinical safe cells, drug and biomaterials effectively promotes spinal cord repair and restores motor functions

Liming Li, Jiafu Mu, Jiachen Chen, Tianchen Huang, Yu Zhang, Youzhi Cai, Tianyuan Zhang, Xianglei Kong, Jihong Sun, Xinchi Jiang, Jiahe Wu, Jian Cao und 4 weitere

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.09.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Liming Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266071, China; College of Pharmaceutical…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Mesenchymal Stem Cell Transplantation, Rats, Sprague-Dawley, Hydrogels. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) is incurable and raises growing concerns. The main barrier to nerve repair is the complicated inhibitory microenvironment, where single-targeted strategies are largely frustrated. Despite the progress in combinatory therapeutic systems, the development and translation of effective therapies remain a challenge with extremely limited clinical materials. In this study, mesenchymal stem cells are transplanted in combination with sustained release of methylprednisolone through delivery in one composite matrix of a microsphere-enveloped adhesive hydrogel. All the materials used, including the stem cells, drug, and the matrix polymers gelatin and hyaluronan, are clinically approved. The therapeutic effects and safety issues are evaluated on rat and canine SCI models. The implantation significantly promotes functional restoration and nerve repair in a severe long-span rat spinal cord transection model. Distant spinal cord segments and the urinary system are effectively protected against pathologic damage. Moreover, the local sustained drug delivery mitigates the inflammatory microenvironment when overcoming the clinical issue of systemic side effects. The study presents an innovative strategy to achieve safe and efficient combinatory treatment of SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesMesenchymal Stem Cell TransplantationRats, Sprague-DawleyHydrogelsMethylprednisoloneAnimalsDogsBiocompatible MaterialsMesenchymal Stem CellsDelayed-Action PreparationsFemaleHyaluronic AcidRecovery of FunctionSpinal CordRatsGelatinMicrospheresSpinal Cord Regeneration

Stichwörter der Autor:innen

HydrogelMesenchymal stem cellsMethylprednisoloneMicrospheresSpinal cord injuryTissue engineering

Substanzen

HydrogelsMethylprednisoloneBiocompatible MaterialsDelayed-Action PreparationsHyaluronic AcidGelatin

Autor:innen und Institutionen

  • School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266071, China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Department of Orthopedics and Center for Sport Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Department of Radiology Sir Run Run Shaw Hospital, School of Medicine Zhejiang University, Hangzhou 310016, China.
  • Institute of Neurobiology, Binzhou Medical University, Yantai 264003, China.
  • The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China.

Förderung

  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program

Zitieren

APA

Li, L., Mu, J., Chen, J., Huang, T., Zhang, Y., Cai, Y., Zhang, T., Kong, X., Sun, J., Jiang, X., Wu, J., Cao, J., Zhang, X., Huang, F., Feng, S., & Gao, J. (2024). An integrated long-acting implant of clinical safe cells, drug and biomaterials effectively promotes spinal cord repair and restores motor functions. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.09.010

Vancouver

Li L, Mu J, Chen J, Huang T, Zhang Y, Cai Y, et al. An integrated long-acting implant of clinical safe cells, drug and biomaterials effectively promotes spinal cord repair and restores motor functions. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.09.010

BibTeX
@article{Li2024,
  author = {Li, Liming and Mu, Jiafu and Chen, Jiachen and Huang, Tianchen and Zhang, Yu and Cai, Youzhi and Zhang, Tianyuan and Kong, Xianglei and Sun, Jihong and Jiang, Xinchi and Wu, Jiahe and Cao, Jian and Zhang, Xunqi and Huang, Fei and Feng, Shiqing and Gao, Jianqing},
  title = {An integrated long-acting implant of clinical safe cells, drug and biomaterials effectively promotes spinal cord repair and restores motor functions},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.09.010}
}
Kostenlos starten →